SurgiLance safety lancets are also used in point-of-care diagnostic testing, including diabetes testing and testing for HIV, said MediPurpose.
Smiths Medical was recently named as exclusive distributor for Europe. The new relationship with Domrex further extends the SurgiLance safety lancet’s reach in the Americas, according to MediPurpose’s CEO Patrick Yi.
Randy Prather, president and COO of MediPurpose, said: “Domrex Pharma is known for its impressive lineup of innovative safety medical devices. Our lancets will now be available in pharmacies across Canada. This is good news for Canadians living with diabetes who need to test blood glucose levels frequently.”
Dominque Ferland, CEO of Domrex Pharma, said: “Domrex has been marketing this device mostly in Ontario and Quebec since March of this year with significant success, and we now have the ability to take this line coast to coast. We have no doubt that this product line will positively impact the quality of healthcare in Canada. Having clinically evaluated every device on the market, we know that the SurgiLance product is truly the top of its class. We are all very excited to work with MediPurpose moving forward.”